Think of it this way: estrogen helps keep the brain's power plants running cleanly and efficiently, while GLP-1 signaling ensures that aging or damaged power plants are replaced before they become a liability
Recent clinical trials have demonstrated that GLP-1RAs have beneficial effects on renal outcomes, especially in patients with T2D who are at high risk for CVD
We found that these altered patterns are increasingly common, yet there is currently no national or international guidance in the UK addressing this emerging issue. Misinterpreting these uptake patterns can lead to unnecessary investigations, inappropriate cancer staging, and delays in treatment, which may cause stress and uncertainty for patients
Now back to this, GLP-1 hormone, which is the star of the drug
Weight Loss Efficacy: recent studies suggest a slight advantage in weight loss potential using Tirzepatide